The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Muromtseva G.A.

National Medical Research Center for Therapy and Preventive Medicine

Shalnova S.A.

National Medical Research Center for Therapy and Preventive Medicine

Yavelov I.S.

National Medical Research Center for Therapy and Preventive Medicine

Ievlev R.V.

Lomonosov Moscow State University

Maksimov S.A.

National Medical Research Center for Therapy and Preventive Medicine

Kapustina A.V.

National Medical Research Center for Therapy and Preventive Medicine

Balanova Yu.A.

National Medical Research Center for Therapy and Preventive Medicine

Evstifeeva S.E.

National Medical Research Center for Therapy and Preventive Medicine

Imaeva A.E.

National Medical Research Center for Therapy and Preventive Medicine

Yarovaya E.B.

National Medical Research Center for Therapy and Preventive Medicine;
Lomonosov Moscow State University

Drapkina O.M.

National Medical Research Center for Therapy and Preventive Medicine

Population portrait of the atrial fibrillation by the ESSE-RF study. Part 2. The relationship of atrial fibrillation with diseases and biological indicators

Authors:

Muromtseva G.A., Shalnova S.A., Yavelov I.S., Ievlev R.V., Maksimov S.A., Kapustina A.V., Balanova Yu.A., Evstifeeva S.E., Imaeva A.E., Yarovaya E.B., Drapkina O.M.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2025;28(12): 43‑51

DOI: 10.17116/profmed20252812143

Read: 557 times

Contact the author
Table of contents

POPULATION PORTRAIT OF THE ATRIAL FIBRILLATION BY THE ESSE-RF STUDY. PART 2. THE RELATIONSHIP OF ATRIAL FIBRILLATION WITH DISEASES AND BIOLOGICAL INDICATORS
POPULATION PORTRAIT OF THE ATRIAL FIBRILLATION BY THE ESSE-RF STUDY. PART 2. THE RELATIONSHIP OF ATRIAL FIBRILLATION WITH DISEASES AND BIOLOGICAL INDICATORS

To cite this article:

Muromtseva GA, Shalnova SA, Yavelov IS, et al. Population portrait of the atrial fibrillation by the ESSE-RF study. Part 2. The relationship of atrial fibrillation with diseases and biological indicators. Russian Journal of Preventive Medicine. 2025;28(12):43‑51. (In Russ.)
https://doi.org/10.17116/profmed20252812143

 
Подписка 2026 Профилактическая медицина (Russian Journal of Preventive Medicine)
МСФ на ЯМ
Использование инфографики авторами научных работ
Recommended articles:
Atrial fibrillation recu­rrences after catheter treatment and labo­ratory markers: is there a correlation?. Russian Journal of Preventive Medi­cine. 2025;(7):56-62
Pote­ntial for the six-minute walk test use in patients with atrial fibrillation. Russian Journal of Preventive Medi­cine. 2025;(10):129-133
Popu­lation portrait of the atrial fibrillation by the ESSE-RF study.. Russian Journal of Preventive Medi­cine. 2025;(11):7-13
Left atrial redu­ction in mitral valve surgery. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(4):460-470
Morphological and immu­nohistochemical characteristics of skin specimens after isolated and combined inje­ctions of poly-L-lactic acid and hyaluronic acid. Plastic Surgery and Aesthetic Medi­cine. 2025;(3):50-62
Visceral obesity is a reve­rsible factor in pathogenesis of major cardiovascular diseases. Russian Cardiology Bulletin. 2025;(3):11-16
Mice and rats wound infe­ction models for testing new drugs under deve­lopment. Mole­cular Gene­tics, Microbiology and Viro­logy. 2025;(3):9-24
TERTp muta­tion screening using digi­tal droplet PCR of collection of 52 paired DNA samples from blood plasma and tumor tissue in patients with glioblastoma. Burdenko's Journal of Neurosurgery. 2025;(5):87-95
Asso­ciation of the BAIAP2L1 gene poly­morphism with the risk of deve­loping geni­tal endo­metriosis in combination with uterine fibroids and endo­metrial hype­rplasia. Russian Bulletin of Obstetrician-Gynecologist. 2025;(6):5-11
Atrial fibrillation and left ventricular dysfunction: cause or consequence (analysis of the dila­ted cardiomyopathy regi­stry). Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(6):619-627
Abstract:

The study of parameters associated with atrial fibrillation (AF) is necessary for optimal organization of prevention of this potentially adverse cardiac arrhythmia.

OBJECTIVE

To perform an analysis of the association of atrial fibrillation with diseases and biological parameters according to the ESSE-RF population study.

MATERIALS AND METHODS

The analysis was carried out on the material of «Epidemiology of Cardiovascular Diseases in regions of the Russian Federation (ESSE-RF)» multicenter epidemiological study — 17693 persons (38.4% men) aged 25—64 years, among them 116 had AF. Univariate and multivariate logistic regression, adjusted for sex and age, were used to evaluate the relationship of the analyzed parameters with AF. Materials and methods are presented in details in the first part of the article.

RESULTS

According to the results of univariate analysis, AF is associated with the presence of arterial hypertension, diabetes mellitus, ischemic heart disease and obesity as well as with a heart rate (HR) >80 b/min and high blood pressure. In addition, the relationship of AF with increased content of uric acid, creatinine, high-sensitivity C-reactive protein, brain natriuretic peptide (BNP), cardiac troponin I (cTnI) and decreased high-density lipoprotein cholesterol level has been determined. Based on the multivariate analysis results, only levels of two biomarkers — BNP and cTnI — were independently associated with the presence of AF.

CONCLUSION

In the Russian population of working age, the relationships of atrial fibrillation with diseases and biological parameters have been studied. Independent associations with atrial fibrillation have been identified only for brain natriuretic peptide and cardiac troponin I. Appearingly, changes in atrial fibrillation related to cardiomyocyte damage and heart remodeling may be more significant than changes in other biological parameters and changes associated with the presence of specific diseases. The obtained result is consistent with the concept of atrial fibrillation pathogenesis.

Keywords:

atrial fibrillation
population study
associations
biological risk factors
biomarkers
odds ratio

Authors:

Muromtseva G.A.

National Medical Research Center for Therapy and Preventive Medicine

Shalnova S.A.

National Medical Research Center for Therapy and Preventive Medicine

Yavelov I.S.

National Medical Research Center for Therapy and Preventive Medicine

Ievlev R.V.

Lomonosov Moscow State University

Maksimov S.A.

National Medical Research Center for Therapy and Preventive Medicine

Kapustina A.V.

National Medical Research Center for Therapy and Preventive Medicine

Balanova Yu.A.

National Medical Research Center for Therapy and Preventive Medicine

Evstifeeva S.E.

National Medical Research Center for Therapy and Preventive Medicine

Imaeva A.E.

National Medical Research Center for Therapy and Preventive Medicine

Yarovaya E.B.

National Medical Research Center for Therapy and Preventive Medicine;
Lomonosov Moscow State University

Drapkina O.M.

National Medical Research Center for Therapy and Preventive Medicine

Received:

24.08.2025

Accepted:

24.09.2025

Close metadata

References:

  1. Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge. International Journal of Stroke. 2021;16:217-221.  https://doi.org/10.1177/1747493019897870
  2. Lemoine M, Rottner L, Kirchhof P. Asymptomatic atrial fibrillation: the tasks ahead. European Heart Journal. 2025;46:1203-1205.
  3. Van Gelder IC, Rienstra M, Bunting KV, et al.; ESC Scientific Document Group. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal. 2024;45:3314-3414. https://doi.org/10.1093/eurheartj/ehae176
  4. Metelskaya VA, Gumanova NG. Valid cardiospecific biochemical markers. Part I. Kardiovaskuljarnaja terapija i profilaktika 2020;19(4):2573. (In Russ.). https://doi.org/10.15829/1728-8800-2020-2573
  5. Arakelyan MG, Bokeria LA, Vasilyeva EYu, et al. Atrial fibrillation and flutter. Clinical guidelines 2020. Rossijskij kardiologicheskij zhurnal. 2021;26(7): 4594. (In Russ.). https://doi.org/10.15829/1560-4071-2021-4594
  6. Quinn FR, McGavigan AD, Rankin AC. Sinus and Atrial Arrhythmias. Atrial Fibrillation. In: Macfarlane PW, van Oosterom A, Pahlm O, Kligfield P, Janse M, Camm J, eds. Comprehensive Electrocardiology. 2d Edition. Springer-Verlag London Limited; 2011;1218-1229. https://doi.org/10.1007/978-1-84882-046-3_40
  7. Lu Y, Sun Y, Cai L, et al. Non-traditional risk factors for atrial fibrillation: epidemiology, mechanisms, and strategies. European Heart Journal. 2025; 46:784-804.  https://doi.org/10.1093/eurheartj/ehae887
  8. Lau DH, Mackenzie L, Kelly DJ, et al. Short-term hypertension is associated with the development of atrial fibrillation substrate: a study in an ovine hypertensive model. Heart Rhythm. 2010;7:396-404.  https://doi.org/10.1016/j.hrthm.2009.11.031
  9. Gapon LI, Samoylova EP, Nistryanu DN, et al. Association of left atrial strain and inflammatory factors in hypertensive patients working in the Arctic. Kardiovaskuljarnaja terapija i profilaktika. 2025;24(5):4277. (In Russ.). https://doi.org/10.15829/1728-8800-2025-4277
  10. Munger TM, Dong YX, Masaki M, et al. Electrophysiological and hemodynamic characteristics associated with obesity in patients with atrial fibrillation. Journal of the American College of Cardiology. 2012;60:851-860.  https://doi.org/10.1016/j.jacc.2012.03.042
  11. Tarasova IV, Vertkin AL. The role of epicardial adipose tissue in the development of atrial fibrillation: a literature review. Lechashhij vrach. 2024; 7(27):17-22. (In Russ.). https://doi.org/10.51793/OS.2024.27.7.002
  12. Metelskaya VA, Timofeev YuS, Neshkova EA, et al. Inflammatory aging. Part 2. Are there diagnostic biomarkers available. The Russian Journal of Preventive Medicine. 2025;28(1):89-95. (In Russ.). https://doi.org/10.17116/profmed20252801189
  13. Gostimsky VA, Avdeeva MV. Cytokine profile in middle-aged men with acute and chronic coronary syndrome and its relation with coronary bed lesion severity. The Russian Journal of Preventive Medicine. 2024;27(10):101-107. (In Russ.). https://doi.org/10.17116/profmed202427101101
  14. Violi F, Soliman EZ, Pignatelli P, et al. Atrial fibrillation and myocardial infarction: a systematic review and appraisal of pathophysiologic mechanisms. Journal of the American Heart Association. 2016;5:e003347.
  15. Annoura M, Ogawa M, Kumagai K, et al. Cholesterol paradox in patients with paroxysmal atrial fibrillation. Cardiology. 1999;92:21-27. 
  16. Blinova NV, Trushina OIu, Kislyak OA, et al. Consensus on the management of patients with hyperuricemia and high cardiovascular risk: 2025. Sistemnye gipertenzii. 2025;22(2):5-17. (In Russ.). https://doi.org/10.38109/2075-082X-2025-2-5-17
  17. Shalnova SA, Deev AD, Artamonov GV, et al. on behalf of the participants of the ESSE-RF study. Hyperuricemia and its correlates in the Russian population (results of ESSE-RF epidemiological study). Racional’naja farmakoterapija v kardiologii. 2014;10(2):153-159. (In Russ.).
  18. Barysenka TL, Snezhitsky VA, Doroshenko EM, et al. Uric Acid Level, Purine Metabolites, and SLC2A9 Gene Polymorphism in Assessing the Risk of Adverse Cardiovascular Events in Patients with Arterial Hypertension and/or Atrial Fibrillation. Kardiologiia v Belarusi. 2024;16(1):36-50. (In Russ.). https://doi.org/10.34883/PI.2024.16.1.003
  19. Shalnova SA, Kutsenko VA, Kapustina AV, et al. Associations of Blood Pressure and Heart Rate and their Contribution to the Development of Cardiovascular Complications and All-Cause Mortality in the Russian Population of 25—64 Years. Racional’naja farmakoterapija v kardiologii. 2020;16(5):759-769. (In Russ.). https://doi.org/10.20996/1819-6446-2020-10-02
  20. Svistunov AA, Golovacheva TV, Skvortsov KYu, et al. Heart rate as a factor of risk of development of cardiovascular diseases (Review). Arterial’naja gipertenzija. 2008;14(4):324-331. (In Russ.).
  21. Shalnov SA, Deev AD, Belova OA, et al. Heart rate and its association with the main risk factors in the population of men and women of working age. Racional’naja farmakoterapija v kardiologii. 2017;13(6):819-826. (In Russ.). https://doi.org/10.20996/1819-6446-2017-13-6-819-826
  22. Cesari M, Penninx BWJH, Newman AB, et al. Inflammatory Markers and Cardiovascular Disease (The Health, Aging and Body Composition [Health ABC] Study. American Journal of Cardiology. 2003;92:522-528. 
  23. Weber M, Hamm C. Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. Heart. 2006;92:843-849.  https://doi.org/10.1136/hrt.2005.071233
  24. Bisov AS, Pobedyonnaya GP, Boichenko PK, et al. Cerebral natriuretic peptide and systemic inflammation factors in the combined course of community-acquired pneumonia and gastroesophageal reflux disease. Juzhno-Rossijskij zhurnal terapevticheskoj praktiki. 2024;5(4):56-63. (In Russ.). https://doi.org/10.21886/2712-8156-2024-5-4-56-63
  25. Farmakis D, Mueller C, Apple FS, et al. High-sensitivity cardiac troponin assays for cardiovascular risk stratification in the general population. European Heart Journal. 2020;41(41):4050-4056. https://doi.org/10.1093/eurheartj/ehaa083
  26. Shalnova SA, Drapkina OM, Kontseva AV, et al. A pilot project to study the association of troponin I with cardiovascular complications in the population of the Russian region. Kardiovaskuljarnaja terapija i profilaktika. 2021; 20(5):2980. (In Russ.). https://doi.org/10.15829/1728-8800-2021-2980
  27. Kaliev KR, Beishenkulov MT, Toktosunova AK, et al. Relationship between renal disfunction, left ventricular diastolic dysfunction and coronary atherosclerosis in patients with non-ST segment elevation acute coronary syndrome. The Russian Journal of Preventive Medicine. 2025;28(1):76-82. (In Russ.). https://doi.org/10.17116/profmed20252801176
  28. Suthahar N, Lau E, Blaha M, et al. Sex-Specific Associations of Cardiovascular Risk Factors and Biomarkers With Incident Heart Failure. Journal of the American College of Cardiology. 2020;76(12):1455-1465. https://doi.org/10.1016/j.jacc.2020.07.044
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.